Regenxbio
RGNX
64 hedge funds and large institutions have $179M invested in Regenxbio in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 24 increasing their positions, 15 reducing their positions, and 12 closing their positions.
60% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 15
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less funds holding
Funds holding: 66 → 64 (-2)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
28% less capital invested
Capital invested by funds: $247M → $179M (-$68.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
+$4.22M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$3.2M |
| 3 |
RIM
RS Investment Management
San Francisco,
California
|
+$2.97M |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
+$2.35M |
| 5 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$1.58M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.94M |
| 2 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$1.98M |
| 3 |
UBS AM
Chicago,
Illinois
|
-$1.81M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$996K |
| 5 |
Millennium Management
New York
|
-$784K |
RGNX Hedge Fund Activity: Q1 2016 in Review
64 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q1 2016, worth a combined $179M — down 28% from $247M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of RGNX and 10 opened new positions — a net loss of 2 holders — while 15 trimmed existing stakes and 24 added.
The largest buyer was Sectoral Asset Management, adding an estimated $4.22M. The largest seller was Fidelity Investments, cutting an estimated $2.94M.
- 64 institutional investors held Regenxbio (RGNX) as of Q1 2016, down from 66 in Q4 2015.
- Funds reported $179M of Regenxbio stock for Q1 2016, down 28% quarter-over-quarter.
- 10 funds opened new Regenxbio positions in Q1 2016 and 12 closed out, a net change of -2 holders.
- The largest Regenxbio buyer in Q1 2016 was Sectoral Asset Management, an estimated $4.22M added.
- The largest Regenxbio seller in Q1 2016 was Fidelity Investments, an estimated $2.94M sold.
Based on aggregated 13F filings for Q1 2016.